NMRA
Neumora Therapeutics
$0.39
+$0.02 (+6.79%)Oct 28, 2026
Key metrics
The numbers that frame NMRA today
- Market cap
- $73.84M
- ROIC
- -597.7%
- Div yield
- 0%
- Debt / equity
- 1.2
- 52wk Low
- $0.32
- 52wk High
- $3.65
Growth
Revenue and earnings trend for NMRA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about NMRA
Is Neumora Therapeutics a good buy?
No. Neumora Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks weak. That could put pressure on the long-term business case. We think Neumora Therapeutics is selling at a very high price.
What is the market capitalization of NMRA?
Neumora Therapeutics's market capitalization is $73.84M.
What is the 52-week high for NMRA stock?
The 52-week high for Neumora Therapeutics is $3.65. The current close of $0.39 is 89.2% below that high.
What is the 52-week low for NMRA stock?
The 52-week low for Neumora Therapeutics is $0.32. The current close of $0.39 is 24.8% above that low.
Does NMRA stock pay dividends?
Neumora Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for NMRA?
Neumora Therapeutics's Debt / Equity ratio is 1.2.